Rare diseases
Investigational molecules
Locations
Back to Austria838 clinical trials in Vienna, Austria across 10 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients
AustriaStudy on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer
AustriaStudy of Rapcabtagene Autoleucel and Ibrutinib for Adults with Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Other Blood Cancers
AustriaStudy comparing iberdomide, daratumumab and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma
AustriaStudy Comparing the Effectiveness and Safety of Macitentan 75 mg and 10 mg for Patients with Pulmonary Arterial Hypertension
AustriaStudy Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation
AustriaStudy on Rimegepant for Treating Migraine in Adults Who Cannot Use Triptans
AustriaStudy on Rimegepant for Preventing Migraines in Adults with Poor Response to Oral Preventive Medications
AustriaStudy on Ceralasertib and Trastuzumab Deruxtecan for Patients with Non-Small Cell Lung Cancer After Anti-PD-1/PD-L1 Therapy
AustriaStudy on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy
AustriaStudy Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer
AustriaStudy on Izokibep for Patients with Non-infectious Uveitis
AustriaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on innovative treatments for various cancer types, including pancreatic ductal adenocarcinoma, gastric cancer, and non-small cell lung cancer. Studies evaluating new therapeutic approaches for breast cancer and multiple myeloma are also underway.
Research includes evaluation of novel drug combinations and immunotherapy approaches for improved patient outcomes.
Investigations into major depression and its treatment mechanisms, including studies on dopamine synthesis and antidepressant effectiveness. Research examines innovative therapeutic approaches using ketamine and other compounds.
Focus on understanding brain activation patterns and treatment responses in psychiatric conditions.
Research on plaque psoriasis, rheumatic diseases, and Sjögren's syndrome. Studies evaluate new biological therapies and treatment approaches for chronic inflammatory conditions.
Emphasis on developing targeted therapies for improved disease management and patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
